• Skip to main content

TricountyUrology.org

  • Home
  • About
    • The Basics
    • Product Intel
  • Men’s Health & Telehealth
    • Male Enhancement
    • Prostate
  • Comparisons & Guides
    • How-To Guides
    • Product Reviews
  • Health Science
    • Wellness

PSA Testing Explained: What You Need to Know

posted on August 25, 2026

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making health decisions based on this content.

By TriCountyUrology Editorial Team | Last verified: August 2026

PSA Testing: A Common Tool for Prostate Health Screening

Type: Blood test measuring prostate-specific antigen protein
Primary Benefit: Early detection of prostate abnormalities (moderate evidence grade); informs shared decision-making for prostate cancer risk
Key Consideration: PSA elevation does not always mean cancer—many benign conditions raise PSA levels
Safety Note: The test itself is safe; the clinical significance of results requires professional interpretation

In This Article

  • What PSA Testing Is: Definition and Classification
  • How PSA Testing Works: The Biology Behind the Test
  • What the Research Shows: PSA Testing Evidence and Guidelines
  • Forms and Interpretation of PSA Testing Results
  • Who Should Consider PSA Testing and Who Should Avoid It
  • Safety and Limitations of PSA Testing
  • Key Takeaway: PSA Testing in Context

What PSA Testing Is: Definition and Classification

PSA (prostate-specific antigen) testing is a blood test that measures the level of a protein produced exclusively by the prostate gland. The prostate is a walnut-sized organ in men that produces fluid for semen. PSA is a normal protein the prostate makes, but elevated levels in the blood can signal potential problems.

PSA testing is classified as a screening test rather than a diagnostic test. This is a critical distinction: a screening test identifies people who may need further evaluation, while a diagnostic test confirms or rules out a specific disease. A PSA test cannot diagnose prostate cancer on its own—it is a starting point for conversation and potential follow-up imaging or biopsy.

The test is performed through a simple blood draw, usually done during a routine office visit or at a laboratory. Results are reported in nanograms per milliliter (ng/mL).

How PSA Testing Works: The Biology Behind the Test

The prostate gland continuously produces PSA as part of normal function. Small amounts of PSA enter the bloodstream naturally. In healthy men, PSA levels remain low and stable.

When the prostate is irritated, enlarged, or abnormal—due to cancer, benign prostatic hyperplasia (BPH), or infection—more PSA leaks into the bloodstream. The blood test measures the total amount of PSA present. A higher PSA level may indicate a problem worth investigating, though elevation alone does not confirm cancer.

PSA levels can be affected by several factors:

  • Age: PSA naturally rises with age in most men
  • Prostate size: Larger prostates produce more PSA
  • Recent ejaculation: Can raise PSA for 24–48 hours
  • Urinary tract infection: Temporarily elevates PSA
  • Vigorous exercise: Particularly cycling, can elevate PSA temporarily
  • Certain medications: Finasteride (Proscar) actually lowers PSA levels
  • Digital rectal exam (DRE): Can modestly raise PSA if performed just before blood draw

What the Research Shows: PSA Testing Evidence and Guidelines

PSA testing has been studied extensively over the past 30 years, with major research trials examining its role in cancer detection and mortality reduction.

Key Evidence:

The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) and the European Randomized Study of Screening for Prostate Cancer (ERSPC) produced the most comprehensive evidence. The ERSPC showed that screening with PSA could reduce prostate cancer mortality by approximately 20%, but at the cost of many men undergoing unnecessary biopsies and treatments (Grade B evidence—moderate quality).

Large-scale studies also documented significant overdiagnosis: many men have slow-growing cancers detected by PSA that would never cause harm or death during their lifetime. This led to unnecessary anxiety, biopsies, and aggressive treatments with side effects like incontinence and erectile dysfunction.

Current Professional Guidelines (2024–2026):

  • American Urological Association (AUA): Recommends shared decision-making for men ages 45–69. Men should discuss benefits and risks with their doctor before starting screening.
  • American Cancer Society: Recommends that men have the opportunity to make informed decisions about screening beginning at age 50 (or 45 for high-risk men, including Black men and those with family history).
  • U.S. Preventive Services Task Force (USPSTF): Does not recommend routine PSA screening for asymptomatic men. Individualized decisions are emphasized.

What “Normal” PSA Means:

  • Below 4.0 ng/mL is traditionally considered normal in most men
  • 4.0–10.0 ng/mL warrants discussion and may prompt further evaluation depending on age, family history, and other factors
  • Above 10.0 ng/mL typically prompts referral to urology for further assessment

However, these cutoffs are not absolute. Age-adjusted ranges and rate of PSA change over time (PSA velocity) are also clinically important.

Forms and Interpretation of PSA Testing Results

Types of PSA Measurements:

Total PSA: The most common test, measuring all PSA in the blood. Simple and widely available.

Free vs. Bound PSA: In some cases, doctors order a “free PSA” percentage test. Higher free PSA (as a percentage of total) may indicate lower cancer risk. This helps refine risk assessment when total PSA is borderline.

PSA Density: PSA level adjusted for prostate size (measured by ultrasound). Useful in men with enlarged prostates.

PSA Velocity: The rate of PSA rise over time. A sharp increase may warrant closer monitoring.

Newer Risk Calculators: Tools like the Prostate Cancer Risk Calculator and the 4Kscore test combine PSA with other factors to refine cancer risk estimates.

Who Should Consider PSA Testing and Who Should Avoid It

Good Candidates for PSA Discussion:

  • Men ages 45–69 with good overall health and life expectancy >10 years
  • Black men and men with a family history of prostate cancer (higher risk group; discussion recommended at age 40–45)
  • Men with symptoms of urinary problems or prostate concerns
  • Men already engaged in shared decision-making with their urologist

When to Avoid or Reconsider PSA Screening:

  • Men with life expectancy less than 10 years (screening unlikely to provide benefit)
  • Men over 75 years old (routine screening not recommended)
  • Men with a history of prostate cancer already under active surveillance or treatment
  • Men with significant comorbidities who would not tolerate prostate biopsy or cancer treatment

Safety and Limitations of PSA Testing

The Test Itself Is Safe: The blood draw carries minimal risk—only minor bruising or infection at the puncture site is possible (extremely rare).

Clinical Risks and Limitations:

  • False positives: Elevated PSA does not mean cancer. Benign conditions—BPH, prostatitis, UTI—cause rises. Many men undergo unnecessary worry and additional testing.
  • Overdiagnosis: Many slow-growing cancers detected would never harm the patient. This leads to overtreatment with surgery or radiation, causing incontinence, erectile dysfunction, and bowel problems.
  • False negatives: A normal PSA does not rule out cancer, though the risk is lower.
  • Psychological impact: An abnormal PSA can cause significant anxiety while waiting for follow-up testing.

Contraindications or Special Precautions:

  • Avoid PSA testing within 48 hours of ejaculation
  • Postpone testing if a urinary tract infection is present (retest after treatment)
  • Account for PSA-lowering medications like finasteride when interpreting results

Key Takeaway: PSA Testing in Context

PSA testing is a useful but imperfect tool. It can help identify men at risk for prostate cancer, but it generates many false alarms. The test is most valuable when used as part of a shared decision-making conversation between a man and his doctor, considering his age, family history, overall health, and personal values.

Routine screening for all men is not recommended by major health organizations. Instead, informed choice is emphasized: men should understand both the potential benefits (early cancer detection in some cases) and the real risks (overdiagnosis, overtreatment, anxiety, and unnecessary biopsies).

If you are considering PSA testing or have received abnormal results, schedule a consultation with a qualified urologist or primary care physician to discuss what is best for your individual situation. The decision should be yours, made with full information and professional guidance.

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.

Related reading: Prostate Health Basics: What You Need to Know | Benign Prostatic Hyperplasia (BPH): What You Need to Know

Filed Under: Prostate

TricountyUrology.org is an independent men's health information website. It is not a medical practice, urology clinic, or healthcare provider. This site is not affiliated with Tricounty Urology Associates or any urology practice in Pennsylvania or elsewhere. This domain was previously used by a medical provider no longer associated with this website. Content is for informational purposes only — not medical advice. Some links are affiliate links; see How This Site Works.

© 2026 TricountyUrology.org — Straight Talk on Men's Health